Cargando…

Effect of PCC on Thrombin Generation among Patients on Factor Xa Inhibitors with Major Bleeding or Needing Urgent Surgery (GAUGE): Design and Rationale

Background Direct factor Xa inhibitors (FXaIs) account for most oral anticoagulant use and FXaI-associated bleeding events are common. Clinicians have variable national and regional access to specific FXaI reversal agents such as andexanet alfa. Many centers have adopted the use of prothrombin comp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shaw, Joseph R., Unachukwu, Ubabuko, Cyr, Joseph, Siegal, Deborah M., Castellucci, Lana A., Dreden, Patrick Van, Dowlatshahi, Dar, Buyukdere, Hakan, Ramsay, Timothy, Carrier, Marc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Georg Thieme Verlag KG 2023
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10368490/ https://www.ncbi.nlm.nih.gov/pubmed/37497426 http://dx.doi.org/10.1055/s-0043-1771300

Ejemplares similares

Comparison of antithrombin‐dependent and direct inhibitors of factor Xa or thrombin on the kinetics and qualitative characteristics of blood clots
por: Salta, Stella, et al.
Publicado: (2018)

Thrombin generation, bleeding and hemostasis in humans: Protocol for a scoping review of the literature
por: Shaw, Joseph R., et al.
Publicado: (2023)

The Tick-Derived Anticoagulant Madanin Is Processed by Thrombin and Factor Xa
por: Figueiredo, Ana C., et al.
Publicado: (2013)

Thrombin and factor Xa link the coagulation system with liver fibrosis
por: Dhar, Ameet, et al.
Publicado: (2018)

Procoagulant activity of human tumours: existence of Xa and thrombin-like activities.
por: Sarode, R., et al.
Publicado: (1990)

The reversal effect of prothrombin complex concentrate (PCC), activated PCC and recombinant activated factor VII against anticoagulation of Xa inhibitor
por: Schultz, Nina Haagenrud, et al.
Publicado: (2017)

Effect modification of age and hypertension on cancer and prevalence of self‐reported stroke – A cross‐sectional study
por: Lun, Ronda, et al.
Publicado: (2023)

Spatial Distribution of Factor Xa, Thrombin, and Fibrin(ogen) on Thrombi at Venous Shear
por: Berny, Michelle A., et al.
Publicado: (2010)

Factor Xa Generation by Computational Modeling: An Additional Discriminator to Thrombin Generation Evaluation
por: Brummel-Ziedins, Kathleen E., et al.
Publicado: (2012)

Lyso-Sulfatide Binds Factor Xa and Inhibits Thrombin Generation by the Prothrombinase Complex
por: Yegneswaran, Subramanian, et al.
Publicado: (2015)

Investigation of the Optimal Dose aPCC in Reversing the Effect of Factor Xa Inhibitors—An In Vitro Study
por: Schultz, Nina Haagenrud, et al.
Publicado: (2021)

Factor Xa inhibition by rivaroxaban in the trough steady state can significantly reduce thrombin generation
por: Horinaka, Shigeo, et al.
Publicado: (2017)

Incidence of stroke in the first year after diagnosis of cancer—A protocol for systematic review and meta-analysis
por: Lun, Ronda, et al.
Publicado: (2021)

Safety of 4-factor prothrombin complex concentrate (4F-PCC) for emergent reversal of factor Xa inhibitors
por: Tao, Jing, et al.
Publicado: (2018)

Andexanet versus prothrombin complex concentrates: Differences in reversal of factor Xa inhibitors in in vitro thrombin generation
por: Lu, Genmin, et al.
Publicado: (2020)

Parallel imaging of coagulation pathway proteases activated protein C, thrombin, and factor Xa in human plasma
por: Modrzycka, Sylwia, et al.
Publicado: (2022)

Thrombin and Factor Xa Hydrolysis of Chromogenic Substrates in the Presence of Sulfated Derivatives of Galactomannan and Galactoglucomannan Natural Gels
por: Drozd, Natalia N., et al.
Publicado: (2022)

Characterization of thrombin/factor Xa inhibitors in Rhizoma Chuanxiong through UPLC-MS-based multivariate statistical analysis
por: Yang, Yi-Yao, et al.
Publicado: (2020)

Reversing direct factor Xa or thrombin inhibitors: Factor V addition to prothrombin complex concentrate is beneficial in vitro
por: Brinkman, Herm Jan M., et al.
Publicado: (2022)

Heavy menstrual bleeding on direct factor Xa inhibitors: Rationale and design of the MEDEA study
por: Hamulyák, Eva N., et al.
Publicado: (2020)

Treatment of Factor-Xa Inhibitor-associated Bleeding with Andexanet Alfa or 4 Factor PCC: A Multicenter Feasibility Retrospective Study
por: Singer, Adam J., et al.
Publicado: (2023)

Alzheimer’s Disease—Rationales for Potential Treatment with the Thrombin Inhibitor Dabigatran
por: Grossmann, Klaus
Publicado: (2021)

Functional assembly of intrinsic coagulation proteases on monocytes and platelets. Comparison between cofactor activities induced by thrombin and factor Xa
Publicado: (1992)

Direct thrombin inhibitors, but not the direct factor Xa inhibitor rivaroxaban, increase tissue factor-induced hypercoagulability in vitro and in vivo
por: Perzborn, E, et al.
Publicado: (2014)

Factor Xa and thrombin induce epithelial-mesenchymal transition by retinal pigment epithelial cells via PDGF-Rβ signaling
por: Bastiaans, Jeroen, et al.
Publicado: (2012)

LC–MS-based multivariate statistical analysis for the screening of potential thrombin/factor Xa inhibitors from Radix Salvia Miltiorrhiza
por: Yang, Yi-Yao, et al.
Publicado: (2020)

Prothrombin complex concentrates for DOAC‐associated bleeding, global coagulation assays, and assessments of clinical hemostasis: How to gauge the impact?
por: Shaw, Joseph R., et al.
Publicado: (2020)

HMGB1 and thrombin mediate the blood-brain barrier dysfunction acting as biomarkers of neuroinflammation and progression to neurodegeneration in Alzheimer’s disease
por: Festoff, Barry W., et al.
Publicado: (2016)

Comparative Evaluation of Direct Thrombin and Factor Xa Inhibitors with Antiplatelet Agents under Flow and Static Conditions: An In Vitro Flow Chamber Model
por: Hosokawa, Kazuya, et al.
Publicado: (2014)

Synthesis and Thrombin, Factor Xa and U46619 Inhibitory Effects of Non-Amidino and Amidino N(2)-Thiophenecarbonyl- and N(2)-Tosylanthranilamides
por: Lee, Soo Hyun, et al.
Publicado: (2017)

Screening of Potential Thrombin and Factor Xa Inhibitors from the Danshen–Chuanxiong Herbal Pair through a Spectrum–Effect Relationship Analysis
por: Wang, Xu, et al.
Publicado: (2021)

Mobile tablet-based therapies following stroke: a systematic scoping review protocol of attempted interventions and the challenges encountered
por: Pugliese, Michael, et al.
Publicado: (2017)

Mobile tablet-based therapies following stroke: A systematic scoping review of administrative methods and patient experiences
por: Pugliese, Michael, et al.
Publicado: (2018)

Endoscopic rescue of anastomotic dehiscence after urgent gastric bypass revision
por: Siegal, Steven R., et al.
Publicado: (2022)

Anticoagulation Monitoring with Activated Partial ThromboPlastin Time and Anti-Xa Activity in Intensive Care Unit Patients: Interest of Thrombin Generation Assay
por: Billoir, Paul, et al.
Publicado: (2022)

An XA21-Associated Kinase (OsSERK2) Regulates Immunity Mediated by the XA21 and XA3 Immune Receptors
por: Chen, Xuewei, et al.
Publicado: (2014)

Xa tantlin lisantiago /
por: Ibarra, José Xochihua
Publicado: (1993)

Coagulation Factor Xa
por: Brown, Mark A., et al.
Publicado: (2013)

Health Equity Implications of the COVID-19 Lockdown and Visitation Strategies in Long-Term Care Homes in Ontario: A Mixed Method Study
por: Saad, Ammar, et al.
Publicado: (2022)

Endothelial Cell Activation and Thrombin Generation Assessment for the Risk of Severe Early Onset Preeclampsia. the ROADMAP-EOP Study
por: Van Dreden, Patrick, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4mmdh3p2agcis06ct9u2519ec1